What is the recommended dose of Kenalog (triamcinolone) for treating cystic acne?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Kenalog (Triamcinolone) for Cystic Acne

For treating cystic acne, triamcinolone acetonide should be used at a concentration of 2.5-5 mg/mL, with 10 mg/mL being diluted with sterile normal saline to achieve these lower concentrations. 1

Dosing Guidelines

Concentration

  • Standard concentration: 2.5 mg/mL (most commonly used by dermatologists) 2
  • Range: 2.5-5 mg/mL (diluted from 10 mg/mL stock) 1
  • Higher concentration (10 mg/mL) is recommended for acne keloidalis 1

Volume

  • Recommended injection volume: 0.05 mL per lesion 2
  • Inject into the center of the lesion 2

Efficacy and Response

  • Flattens most acne nodules within 48-72 hours 1
  • Highly effective for occasional or particularly stubborn cystic lesions 1
  • Not recommended as a treatment strategy for patients with multiple lesions 1

Contraindications

Intralesional triamcinolone should not be used in patients with:

  • Active infections at the injection site (impetigo, herpes) 1
  • Previous hypersensitivity to triamcinolone 1
  • Active tuberculosis or systemic fungal infection (avoid large injections) 1
  • Extensive plaque psoriasis, pustular psoriasis, or erythrodermic psoriasis 1
  • Active peptic ulcer disease 1
  • Uncontrolled diabetes, heart failure, or severe hypertension 1
  • Severe depression or psychosis 1

Potential Adverse Effects

  • Local overdose can result in:
    • Skin atrophy
    • Pigmentary changes
    • Telangiectasias
    • Hypertrichosis 1
  • Other potential complications:
    • Infections
    • Impaired wound healing
    • Contact allergic dermatitis (from benzyl alcohol preservative)
    • Sterile abscess
    • Steroid acne 1
    • Granulomatous reactions (rare) 3
  • When atrophy occurs, it may last over six months 2

Clinical Pearls

  1. Counsel patients about potential adverse effects (hypopigmentation and atrophy) before injection 2
  2. Most dermatologists report that less than 1% of patients return with adverse events 2
  3. Consider combination therapy with intralesional antibiotics for enhanced efficacy:
    • A study showed that combining intralesional triamcinolone with lincomycin provided 100% improvement versus 66% improvement with triamcinolone alone 4
  4. For severe nodulocystic acne with multiple lesions, consider systemic treatments instead:
    • Oral isotretinoin (0.5-1 mg/kg/day) 1, 5
    • Oral antibiotics (doxycycline, minocycline) with topical therapy 5

Treatment Algorithm

  1. For isolated cystic acne lesions:

    • Use triamcinolone 2.5 mg/mL, 0.05 mL per lesion
    • Inject into the center of the lesion
    • Expect improvement within 48-72 hours
  2. For multiple cystic lesions or recurrent disease:

    • Consider systemic therapy instead of multiple intralesional injections
    • Oral isotretinoin or antibiotics with topical therapy would be more appropriate

Remember that intralesional triamcinolone is best suited for occasional stubborn cystic lesions rather than widespread disease 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dermatologist Use of Intralesional Triamcinolone in the Treatment of Acne.

The Journal of clinical and aesthetic dermatology, 2020

Guideline

Treatment of Cutibacterium acnes Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.